A real‐world study of low‐dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource‐constrained target population-Reference-Cited by-同舟云学术

A real‐world study of low‐dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource‐constrained target population

Published:2022-08-04 Issue:1 Volume:62 Page:48-55
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Bathula Savitha¹,Sardana Kabir¹^ORCID,Mathachan Sinu Rose¹,Khurana Ananta¹^ORCID,Ahuja Arvind²,Paliwal Purnima²

Affiliation:

1. Department of Dermatology, Venereology and Leprosy Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital New Delhi India

2. Department of Pathology Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital New Delhi India

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.16315

Reference25 articles.

1. The Mortality Associated with Erythema Nodosum Leprosum in Ethiopia: A Retrospective Hospital-Based Study

2. Interventions for erythema nodosum leprosum;Van Veen NH;Cochrane Database Syst Rev,2009

3. Effectiveness of Thalidomide for Erythema Nodosum Leprosum (ENL):

4. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum

5. A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The perils of prescribing second line anti-leprosy therapy for erythema nodosum leprosum ignoring resistance testing data;Indian Journal of Dermatology, Venereology and Leprology;2024-05-29

2. Access to thalidomide;Leprosy Review;2023-09-01

3. Prednisolone;Reactions Weekly;2023-04-22

4. Low dose thalidomide and its exquisite responsiveness in steroid dependent ENL – a cost effective treatment & emergent need for trials;Leprosy Review;2023-03-01